
Dexcom’s over-the-counter nod sets stage for broader CGM use
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. The Food and Drug Administration cleared the
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. The Food and Drug Administration cleared the
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Roche shared details of its
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Baxter International will close its
A new monoclonal antibody product to protect against respiratory syncytial virus was 90% effective at preventing little children from being hospitalized with RSV, according to
Psychedelic drug developer MindMed today announced that the FDA has granted breakthrough therapy designation to its LSD candidate (MM120) for the treatment of generalised anxiety
Share this article The round secures funding for the company through 2026. Image credit: Shutterstock/OlekStock. Sionna Therapeutics has continued raising capital, closing a $182m Series
Rise and shine, everyone, another busy day is on the way. Moreover, this is shaping up to be a sunny one, as well. This is
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here
The potential of COVID-19 booster vaccine products (antibodies) passed from mother to offspring through breastmilk.
A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts